SCHEMBL2462884

SCHEMBL2462884

COCc1[nH]c2ncnn2c(=O)c1Cc1cccc(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 1/20 0.44
CCR2 P41597 8/20 0.39
ALKBH3 Q96Q83 1/20 0.39
DAO P14920 1/20 0.39
MAOB P27338 2/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
PDE1B Q01064 3/20 0.38
CCR5 P51681 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAOA P21397 1/20 0.36
NR3C1 P04150 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2461078 0.90 ENPP1 (0.42) ENPP1CCR2ALKBH3PDE1BCCR5
SCHEMBL2457593 0.86 ENPP1 (0.43) ENPP1CCR2ALKBH3DAOPDE1B
SCHEMBL2462543 0.85 ENPP1 (0.45) ENPP1CCR2ALKBH3DAOMAOB
SCHEMBL2455657 0.84 ENPP1 (0.50) ENPP1CCR2ALKBH3DAOPDE3B
SCHEMBL2459450 0.83 ENPP1 (0.47) ENPP1CCR2ALKBH3DAOPDE1B
SCHEMBL2455177 0.82 NR3C1 (0.46) ENPP1CCR2ALKBH3DAOPDE1B
SCHEMBL2457283 0.82 ENPP1 (0.46) ENPP1CCR2ALKBH3PDE1BCCR5
SCHEMBL2462646 0.82 CCR2 (0.45) CCR2ALKBH3CCR5
SCHEMBL2461260 0.81 CCR2 (0.48) ENPP1CCR2ALKBH3DAOPDE1B
SCHEMBL2458532 0.81 ENPP1 (0.45) ENPP1CCR2ALKBH3DAOPDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO claimed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed